InsiderClue
Insiders · Profile

RIGGS RORY B

Director at Royalty Pharma · Chief Executive Officer at Cibus · Director at KYNTRA BIO. Filing since 12 Dec 2002. CIK 0001016835

RPRX Royalty Pharma plc Director · 32 trades CBUS Cibus, Inc. Chief Executive Officer · 2 trades KYNB KYNTRA BIO, INC. Director · 7 trades
Company
Date
Role
Action
Shares
Amount
Of holding
RPRX Royalty Pharma plc
4 Jan 2024
Director
Sold on a plan
35,702
$983.50K
64.0%
RPRX Royalty Pharma plc
3 Jan 2024
Director
Sold on a plan
199,098
$5.53M
78.1%
RPRX Royalty Pharma plc
2 Jan 2024
Director
Sold on a plan
235,200
$6.71M
48.0%
CBUS Cibus, Inc.
12 Dec 2023
Chief Executive Officer
Bought
517,107
$5.47M
46.8%
CBUS Cibus, Inc.
1 Jun 2023
Chief Executive Officer
Bought
1,000
$31.50K
0.1%
RPRX Royalty Pharma plc
22 May 2023
Director
Sold at will
1,750,000
$57.44M
99.6%
RPRX Royalty Pharma plc
30 Mar 2023
Director
Sold at will
130,024
$4.71M
8.2%
RPRX Royalty Pharma plc
29 Mar 2023
Director
Sold at will
9,926
$366.77K
0.6%
RPRX Royalty Pharma plc
9 Dec 2022
Director
Sold, plan not stated
19,990
$840.94K
12.8%
RPRX Royalty Pharma plc
17 Nov 2022
Director
Sold, plan not stated
120,000
$5.08M
43.4%
RPRX Royalty Pharma plc
15 Sep 2022
Director
Sold, plan not stated
52,025
$2.20M
15.8%
RPRX Royalty Pharma plc
14 Sep 2022
Director
Sold, plan not stated
47,975
$2.03M
12.7%
RPRX Royalty Pharma plc
9 Aug 2022
Director
Sold, plan not stated
45,000
$1.97M
10.7%
RPRX Royalty Pharma plc
29 Jun 2022
Director
Sold, plan not stated
30,000
$1.27M
6.6%
RPRX Royalty Pharma plc
20 May 2022
Director
Sold, plan not stated
123,696
$4.86M
21.5%
RPRX Royalty Pharma plc
19 May 2022
Director
Sold, plan not stated
26,304
$1.05M
4.4%
RPRX Royalty Pharma plc
29 Mar 2022
Director
Sold, plan not stated
60,000
$2.32M
9.1%
RPRX Royalty Pharma plc
21 Mar 2022
Director
Sold, plan not stated
39,867
$1.56M
100%
RPRX Royalty Pharma plc
18 Mar 2022
Director
Sold, plan not stated
129,222
$5.11M
90.0%
RPRX Royalty Pharma plc
29 Dec 2021
Director
Sold, plan not stated
75,000
$3.00M
11.2%
RPRX Royalty Pharma plc
28 Dec 2021
Director
Sold, plan not stated
109,448
$4.40M
26.6%
RPRX Royalty Pharma plc
17 Nov 2021
Director
Sold, plan not stated
139,389
$5.90M
21.8%
RPRX Royalty Pharma plc
17 Nov 2021
Director
Sold, plan not stated
62,435
$2.65M
9.1%
RPRX Royalty Pharma plc
16 Nov 2021
Director
Sold, plan not stated
12,565
$527.81K
1.8%
RPRX Royalty Pharma plc
29 Sep 2021
Director
Sold, plan not stated
63,777
$2.32M
6.6%
RPRX Royalty Pharma plc
29 Sep 2021
Director
Sold, plan not stated
24,648
$899.71K
3.9%
RPRX Royalty Pharma plc
28 Sep 2021
Director
Sold, plan not stated
40,000
$1.47M
5.9%
RPRX Royalty Pharma plc
29 Jun 2021
Director
Sold, plan not stated
481,000
$19.84M
12.2%
RPRX Royalty Pharma plc
28 Jun 2021
Director
Sold, plan not stated
167,448
$7.05M
4.1%
RPRX Royalty Pharma plc
25 Jun 2021
Director
Sold, plan not stated
666,464
$28.47M
41.6%
RPRX Royalty Pharma plc
7 Jun 2021
Director
Bought
273,650
$12.39M
15.1%
RPRX Royalty Pharma plc
20 Oct 2020
Director
Sold, plan not stated
463,200
$19.45M
100%
RPRX Royalty Pharma plc
18 Jun 2020
Director
Bought
15,000
$420.00K
opened
KYNB KYNTRA BIO, INC.
13 Mar 2018
Director
Sold, plan not stated
12,402
$671.74K
3.2%
KYNB KYNTRA BIO, INC.
12 Mar 2018
Director
Sold, plan not stated
19,693
$1.08M
4.8%
KYNB KYNTRA BIO, INC.
9 Mar 2018
Director
Sold, plan not stated
22,905
$1.28M
5.3%
KYNB KYNTRA BIO, INC.
13 Sep 2017
Director
Sold, plan not stated
25,000
$1.30M
5.4%
KYNB KYNTRA BIO, INC.
16 Dec 2016
Director
Sold, plan not stated
20,000
$417.31K
4.2%
KYNB KYNTRA BIO, INC.
14 Sep 2015
Director
Sold, plan not stated
25,571
$704.74K
5.1%
KYNB KYNTRA BIO, INC.
11 Sep 2015
Director
Sold, plan not stated
24,429
$675.93K
4.6%
RPRX Royalty Pharma plc
12 Dec 2002
Director
Sold, plan not stated
40,010
$1.68M
29.3%
41 decisions on file.